Cargando…

TOR-inhibitors as gero-suppressors

Detalles Bibliográficos
Autor principal:	Nikiforov, Mikhail
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712329/ https://www.ncbi.nlm.nih.gov/pubmed/26796970

Ejemplares similares

Rapid and simple detection of gero-suppressive agents
por: Darzynkiewicz, Zbigniew
Publicado: (2015)

Sarcopenia, Frailty, and Gero-Science: A Decade of Progress and a Bright Future of Discovery
por: Fielding, Roger A.
Publicado: (2020)

Gero Miesenböck: instructing the nervous system
por: Wells, William A.
Publicado: (2007)

Berberine suppresses gero-conversion from cell cycle arrest to senescence
por: Zhao, Hong, et al.
Publicado: (2013)

TRANSFORMING DEMENTIA SERVICE DELIVERY: THE MENTAL HEALTH GERO-CHAMPIONS PROGRAM
por: Koepp, Regina M
Publicado: (2019)

Prospective GERiatric Observational (ProGERO) study: cohort design and preliminary results
por: Saraiva, Marcos Daniel, et al.
Publicado: (2020)

A gero-informatics tool to enhance the care of hospitalized older adults with cognitive impairment
por: Boustani, Malaz, et al.
Publicado: (2007)

GNSS-R Altimetry Performance Analysis for the GEROS Experiment on Board the International Space Station
por: Camps, Adriano, et al.
Publicado: (2017)

Assessing the impact of COVID-19 on the health of geriatric patients: The European GeroCovid Observational Study
por: Trevisan, Caterina, et al.
Publicado: (2021)

Frailty and hyperactive delirium in hospitalized older patients with COVID-19: an insight from GeroCovid registry
por: Parrotta, Ilaria, et al.
Publicado: (2023)

Health trajectories in older patients hospitalized for COVID-19: Results from the GeroCovid multicenter study
por: Trevisan, Caterina, et al.
Publicado: (2023)

Monitoring COVID-19 vaccine use in Italian long term care centers: The GeroCovid VAX study
por: Abbatecola, Angela Marie, et al.
Publicado: (2022)

Clinical presentation and prognosis of COVID-19 in older adults with hypothyroidism: data from the GeroCovid observational study
por: Bagalà, V., et al.
Publicado: (2023)

The Role of Companion Dogs in the VA Maryland Health Care System Whole Health(y) GeroFit Program
por: Ortmeyer, Heidi K., et al.
Publicado: (2023)

GERO Cohort Protocol, Chile, 2017–2022: Community-based Cohort of Functional Decline in Subjective Cognitive Complaint elderly
por: Slachevsky, Andrea, et al.
Publicado: (2020)

Psychological Well-Being of Older Adults With Cognitive Deterioration During Quarantine: Preliminary Results From the GeroCovid Initiative
por: Coin, Alessandra, et al.
Publicado: (2021)

Two Years with COVID-19: The Electronic Frailty Index Identifies High-Risk Patients in the Stockholm GeroCovid Study
por: Mak, Jonathan K.L., et al.
Publicado: (2022)

Clinical profile of trazodone users in a multisetting older population: data from the Italian GeroCovid Observational study
por: Coin, Alessandra, et al.
Publicado: (2023)

Atrial fibrillation and COVID-19 in older patients: how disability contributes to shape the risk profile. An analysis of the GeroCovid registry
por: Fumagalli, Stefano, et al.
Publicado: (2021)

Determinants of Cause-Specific Mortality and Loss of Independence in Older Patients following Hospitalization for COVID-19: The GeroCovid Outcomes Study
por: Okoye, Chukwuma, et al.
Publicado: (2022)

Ro io̲n'fe̲ni hnini ñuhu Huasteca ne pont imajuäni gero hie mayabu̲ = Memoria del pueblo ñuhu de la Huasteca veracruzana sobre sus vestimentas tradicionales
por: Rodríguez Sánchez, Beatriz
Publicado: (2005)

Clinical Features of SARS-CoV-2 Infection in Italian Long-Term Care Facilities: GeroCovid LTCFs Observational Study
por: Malara, Alba, et al.
Publicado: (2022)

Gerosuppression by pan-mTOR inhibitors
por: Leontieva, Olga V., et al.
Publicado: (2016)

Walking the tightrope: UCH-L1 as an mTOR inhibitor and B-cell oncogene
por: Bedekovics, Tibor, et al.
Publicado: (2019)

Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
por: Villar, Victor H., et al.
Publicado: (2017)

Decreased Mortality Over Time During the First Wave in Patients With COVID-19 in Geriatric Care: Data From the Stockholm GeroCovid Study
por: Xu, Hong, et al.
Publicado: (2021)

Dementia and psychotropic medications are associated with significantly higher mortality in geriatric patients hospitalized with COVID-19: data from the StockholmGeroCovid project
por: Secnik, Juraj, et al.
Publicado: (2023)

mTOR inhibitor efficacy is determined by the eIF4E/4E-BP ratio
por: Alain, Tommy, et al.
Publicado: (2012)

How do mTOR inhibitors fit in the landscape of treatment for relapsed acute lymphoblastic leukemia?
por: Pinchinat, Ashley, et al.
Publicado: (2022)

Tumor suppressors revival in CLL
por: Carrà, Giovanna, et al.
Publicado: (2017)

Sex differences in the efficacy and safety of SARS-CoV-2 vaccination in residents of long-term care facilities: insights from the GeroCovid Vax study
por: Trevisan, Caterina, et al.
Publicado: (2023)

Targeting glutaminase and mTOR
por: Tanaka, Kazuhiro, et al.
Publicado: (2015)

mTOR in cerebrovascular disease
por: Van Skike, Candice E., et al.
Publicado: (2019)

mTOR in Human Diseases
por: Dormond, Olivier
Publicado: (2019)

Tumor suppressor prostaglandin D(2)
por: Maeda, Shingo, et al.
Publicado: (2014)

GCN2 and TOR converge on aging
por: Vlanti, Anna, et al.
Publicado: (2013)

mTOR Signaling in Metabolism and Cancer
por: Huang, Shile
Publicado: (2020)

Potential of mTOR inhibitors for the treatment of subependymal giant cell astrocytomas in tuberous sclerosis complex
por: Major, Philippe
Publicado: (2011)

Arresting kinase suppressor of Ras in an inactive state
por: Badshah, Syed Lal, et al.
Publicado: (2017)

PHLPP1 is a metastasis suppressor in melanoma
por: Dai, Meng, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_18jqp35t20f63323qb8ibdqsu9